A passive holder reducing its stake is routine and not a signal of changing fundamentals. Monitor next 13F for broader institutional positioning trends, but this filing alone does not indicate a shift in investment thesis.
Price Chart
How similar events traded
Executive Summary
Toronto Dominion Bank filed an amended Schedule 13G disclosing a reduced passive stake in UroGen Pharma of 2,886,236 shares (5.9% of outstanding shares) as of September 30, 2026, down from 6.3% reported by BlackRock in the prior filing. The decrease reflects routine portfolio adjustments by a passive institutional holder.
Key Financial Metrics
Key Facts
- Toronto Dominion Bank (TD Bank) and its subsidiary TD Securities Inc. filed an amended Schedule 13G for UroGen Pharma Ltd.
- As of September 30, 2026, TD Bank beneficially owned 2,770,530 shares and TDSI owned 115,706 shares, for a combined 2,886,236 shares.
- The combined stake represents 5.9% of UroGen's outstanding ordinary shares.
- This is a decrease from the prior filing (BlackRock's 6.3% stake as of September 30, 2026), though the prior filing was by a different filer; TD Bank's own prior stake is not provided in the documents.
- TD Bank disclaims beneficial ownership of TDSI's shares except to the extent of its pecuniary interest.
- The filing certifies the securities were acquired and are held in the ordinary course of business, not with the purpose of changing or influencing control.
Financial Impact
TD Bank's combined stake of 2,886,236 shares valued at approximately $167M based on $1.3B market cap and 5.9% stake.
Risk Factors
- No material risks identified from this routine passive stake amendment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000947263-26-000091 |
| Document: 0000947263-26-000091-index.html | 0000947263-26-000091 |
| Document: 0000947263-26-000091.txt | 0000947263-26-000091 |
Track record
16 reports on URGN
5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +54.89% at T+60 after the Mar 2, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Viewing Entry $25.90 Now $28.10 +8.49% settles Nov 23
- Nov 4, 202612d ago 8-K Neutral 5/10 No price data
- Nov 4, 202612d ago Press Release Bearish 6/10 Entry $28.74 to $26.10 Now $28.10 +2.23% ▲ +9.19% +8.27% vs SPY
- Nov 2, 202614d ago Press Release Neutral 4/10 Entry $34.36 to $26.31 Now $28.10 −18.22% ▼ −23.43% −23.51% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $33.75 to $28.74 Now $28.10 −16.74% ▼ −14.84% −14.13% vs SPY
- Oct 19, 202628d ago Press Release Bullish 6/10 Entry $34.15 to $34.23 Now $28.10 −17.72% ▲ +0.23% +0.38% vs SPY
- Oct 9, 20265w ago 144 Neutral 2/10 Entry $36.83 to $34.56 Now $28.10 −23.70% ▼ −6.16% −4.20% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 2/10 Entry $45.00 to $43.04 Now $28.10 −37.56% ▼ −4.36% −4.02% vs SPY
- Aug 20, 202612w ago 8-K Neutral 4/10 Entry $46.80 to $45.50 Now $28.10 −39.96% ▼ −2.78% −3.89% vs SPY
- Aug 5, 202614w ago 8-K Bullish 7/10 Entry $46.43 to $49.00 Now $28.10 −39.48% ▲ +5.54% +5.18% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers